2023-10-20 01:10:32
On October 16th, the 240MeV superconducting medical cyclotron developed by Hefei CAS Ion Medical and Technical Devices Co., Ltd. (HFCIM) was successfully installed at the Proton Therapy Research Center of Huazhong University of Science and Technology, which marks another delivery of medical cyclotron by HFCIM following the former one in Hefei superconducting proton therapy system.
At 11:00 AM, a large crane slowly hoisted the cyclotron, lowering it steadily into the Proton Therapy Research Center at Huazhong University of Science and Technology. The cyclotron, characterized by its compact structure and high efficiency, iscapable of meeting the demands for rapid intensity-modulated radiotherapy (IMRT) and Flash therapy in cancer treatment. It will serve as the particle source for the proton therapy system at the Proton Therapy Research Center of Huazhong University of Science and Technology.
In the delivery ceremony, Gao Liang, a member of the Party Committee and Vice President of Huazhong University of Science and Technology, praised the professional R&D team, effective organization, and resource support. He also commended HFCIM's professional and reliable equipment maintenance, acknowledging HFCIM as a precision radiotherapy system research and development company. He expressed confidence that the successful installation of the cyclotron will effectively propel the construction of the Proton Therapy Research Center at Huazhong University of Science and Technology.
The successful delivery of the cyclotron indicates that HFCIM has acquired the capability for standardized production and on-site delivery. Next, HFCIM will continue to coordinate its advantageous resources, accelerating the on-site installation and debugging of the cyclotron. HFCIM looks forward to further collaboration with Huazhong University of Science and Technology, jointly advancing the high-quality development of the proton therapy industry. The company aims to contribute significantly to the construction of a healthy China.
To learn more, click on the video below: